This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q61793959
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel article scientifique publié en 2015 наукова стаття, опублікована в жовтні 2015 im Oktober 2015 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q61793959-58AB0A05-B059-49FF-A95D-223A8B468FA3
wdt:P577
2015-10-01T00:00:00Z
p:P407
wds:Q61793959-95176B04-EB16-4BCF-966A-4D616B58420E
wdt:P407
wd:Q1860
rdfs:label
TCT-572 Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial TCT-572 Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial
skos:prefLabel
TCT-572 Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial TCT-572 Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial
schema:name
TCT-572 Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial TCT-572 Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial
p:P50
wds:Q61793959-BC497A12-97B5-40F4-A1B4-09D4BE43B699 wds:Q61793959-C7E98383-6B37-4420-8035-32139DC1B1BF wds:Q61793959-03D6B5B4-8D90-4955-8FEA-D93FFABD644F wds:Q61793959-D65443FB-AAF9-4F7A-BCF3-1F518556ACBD wds:Q61793959-EC460E4E-3EC1-426C-9A23-029C77596684 wds:Q61793959-26526079-6443-4C42-96EA-FFB79F80A566 wds:Q61793959-F393A092-BFC3-422A-9D63-E51EC051698E wds:Q61793959-31C5EFC6-72E8-4BDA-88DE-2CF14D6A01CC wds:Q61793959-4A4C0755-506A-4963-8A47-B0DB8240C9AF wds:Q61793959-4E4EC4FE-6E3A-401F-93C4-ED22710BAFCE wds:Q61793959-643E552F-7EF3-4CE0-A315-FB34FA7E990F wds:Q61793959-B42AE5B1-8032-4994-BE0A-E012B14DDDC7
wdt:P50
wd:Q64003260 wd:Q41702487 wd:Q85207405 wd:Q85207407 wd:Q85197692 wd:Q114261314 wd:Q114261299 wd:Q114261302 wd:Q114261335 wd:Q87994590 wd:Q114261366 wd:Q42602665
p:P1476
wds:Q61793959-7B95DCFF-128C-4BFE-92C8-21E9073143B5
wdt:P1476
TCT-572 Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial
p:P304
wds:Q61793959-1D7C2664-6428-4EA2-B10F-68E396B4A1E7
wdt:P304
B232
p:P31
wds:Q61793959-84D5BE3E-17D0-4434-9821-E0B6D9C23DDD
wdt:P31
wd:Q13442814
p:P1433
wds:Q61793959-77B96EE8-C1FA-4CD6-96A3-6C10ED2FAFB4
wdt:P1433
wd:Q2984355
p:P433
wds:Q61793959-414BFF65-74F2-404F-A35B-6E91A6D1560A
p:P478
wds:Q61793959-C88060D7-EA67-49E9-AEFB-ED8BBAD63667
wdt:P433
15
wdt:P478
66
p:P356
wds:Q61793959-7ADCD1E3-0691-46C2-BCA1-BD7175048085
wdtn:P356
n10:J.JACC.2015.08.1042
wdt:P356
10.1016/J.JACC.2015.08.1042